Olateju OA, Zeng Z, Thornton JD, Mgbere O, et al. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer 2023;23:655.
PMID: 37442992